Sonja Sorensen

2.5k total citations
48 papers, 2.0k citations indexed

About

Sonja Sorensen is a scholar working on Economics and Econometrics, Cardiology and Cardiovascular Medicine and Infectious Diseases. According to data from OpenAlex, Sonja Sorensen has authored 48 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Economics and Econometrics, 10 papers in Cardiology and Cardiovascular Medicine and 9 papers in Infectious Diseases. Recurrent topics in Sonja Sorensen's work include Health Systems, Economic Evaluations, Quality of Life (22 papers), Atrial Fibrillation Management and Outcomes (8 papers) and CAR-T cell therapy research (6 papers). Sonja Sorensen is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (22 papers), Atrial Fibrillation Management and Outcomes (8 papers) and CAR-T cell therapy research (6 papers). Sonja Sorensen collaborates with scholars based in United States, United Kingdom and Germany. Sonja Sorensen's co-authors include Dennis A. Revicki, Paul N. Maton, Albert W. Wu, Jonathan Plumb, Alkis Togias, Nancy Kline Leidy, Siyang Peng, Joseph Doyle, Susan C. Fagan and David Fivenson and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cancer.

In The Last Decade

Sonja Sorensen

46 papers receiving 1.9k citations

Peers

Sonja Sorensen
H. Allemand France
Yu‐Tung Huang Taiwan
Aaron S. Fink United States
Luca Neri Italy
Valerie A. Palda Canada
Ning Smith United States
Montserrat Vera‐Llonch United States
José L. Pascual United States
Judith Charlton United Kingdom
David C. Rhew United States
H. Allemand France
Sonja Sorensen
Citations per year, relative to Sonja Sorensen Sonja Sorensen (= 1×) peers H. Allemand

Countries citing papers authored by Sonja Sorensen

Since Specialization
Citations

This map shows the geographic impact of Sonja Sorensen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sonja Sorensen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sonja Sorensen more than expected).

Fields of papers citing papers by Sonja Sorensen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sonja Sorensen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sonja Sorensen. The network helps show where Sonja Sorensen may publish in the future.

Co-authorship network of co-authors of Sonja Sorensen

This figure shows the co-authorship network connecting the top 25 collaborators of Sonja Sorensen. A scholar is included among the top collaborators of Sonja Sorensen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sonja Sorensen. Sonja Sorensen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Li, Nan, et al.. (2025). Budget impact analysis of long-acting injections for the treatment of Schizophrenia in Japan. Asian Journal of Psychiatry. 107. 104455–104455.
3.
4.
Xiao, Ying, et al.. (2019). Economic Evaluation of Nivolumab Plus Ipilimumab Combination as First-Line Treatment for Patients with Advanced Melanoma in Canada. PharmacoEconomics - Open. 3(3). 321–331. 7 indexed citations
5.
Sorensen, Sonja, Mark Wildgust, Nishan Sengupta, et al.. (2017). Indirect Treatment Comparisons of Ibrutinib Versus Physician’s Choice and Idelalisib Plus Ofatumumab in Patients With Previously Treated Chronic Lymphocytic Leukemia. Clinical Therapeutics. 39(1). 178–189.e5. 7 indexed citations
6.
Pan, Feng, Ying Zheng, Irina Proskorovsky, et al.. (2017). Modeling Clinical Outcomes in Prostate Cancer: Application and Validation of the Discrete Event Simulation Approach. Value in Health. 21(4). 416–422. 13 indexed citations
7.
Zheng, Ying, Feng Pan, & Sonja Sorensen. (2016). Modeling Treatment Sequences in Pharmacoeconomic Models. PharmacoEconomics. 35(1). 15–24. 17 indexed citations
8.
Clemens, Andreas, Siyang Peng, Martina Brueckmann, et al.. (2014). Efficacy and Cost-Effectiveness of Dabigatran Etexilate Versus Warfarin in Atrial Fibrillation in Different Age Subgroups. The American Journal of Cardiology. 114(6). 849–855. 19 indexed citations
9.
Feldman, M., et al.. (2013). Modeling hard clinical end-point data in economic analyses. Journal of Medical Economics. 16(11). 1327–1343. 4 indexed citations
10.
Feldman, M., et al.. (2013). Cost-effectiveness of new oral anticoagulants in the prevention of stroke in patients with atrial fibrillation. Best Practice & Research Clinical Haematology. 26(2). 225–237. 26 indexed citations
11.
Bradley-Kennedy, Carole, Andreas Clemens, Brigitta U. Monz, et al.. (2012). Dabigatran versus rivaroxaban for the prevention of stroke and systemic embolism in atrial fibrillation in Canada. Thrombosis and Haemostasis. 108(10). 672–682. 47 indexed citations
12.
Sorensen, Sonja, Feng Pan, Connie Chen, et al.. (2012). INCIDENCE-BASED COST-OF-ILLNESS MODEL FOR METASTATIC BREAST CANCER IN THE UNITED STATES. International Journal of Technology Assessment in Health Care. 28(1). 12–21. 62 indexed citations
13.
14.
Frick, Kevin D., Sonja Sorensen, & Christopher S. Hollenbeak. (2008). How Inducing Covariation in Simulated HDL-C, Triglyceride, and Total Cholesterol Data Affects Framingham Risk Equation Results. Value in Health. 11(5). 939–945. 2 indexed citations
15.
16.
Sorensen, Sonja, et al.. (2006). A Taxonomy and Economic Consequences of Nursing Home Falls. Drugs & Aging. 23(3). 251–262. 33 indexed citations
17.
Sorensen, Sonja. (2004). Cost-Effectiveness of Linezolid versus Vancomycin in the Treatment of Complicated Skin and Soft Tissue Infection due to Proven or Suspected MRSA. 1 indexed citations
18.
Halpern, Michael T., Sonja Sorensen, David Covert, & John E. Hutton. (2000). Longitudinal glaucoma treatment patterns with brinzolamide versus dorzolamide. Journal of Medical Economics. 3. 111–120. 3 indexed citations
19.
Lissovoy, Gregory de, et al.. (2000). Cost for Inpatient Care of Venous Thrombosis. Archives of Internal Medicine. 160(20). 3160–3160. 35 indexed citations
20.
Revicki, Dennis A., Sonja Sorensen, & Albert W. Wu. (1998). Reliability and Validity of Physical and Mental Health Summary Scores from the Medical Outcomes Study HIV Health Survey. Medical Care. 36(2). 126–137. 208 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by H. Allemand Breakdown of academic impact, for papers by Yu‐Tung Huang Breakdown of academic impact, for papers by Aaron S. Fink Breakdown of academic impact, for papers by Luca Neri Breakdown of academic impact, for papers by Valerie A. Palda Breakdown of academic impact, for papers by Ning Smith Breakdown of academic impact, for papers by Montserrat Vera‐Llonch Breakdown of academic impact, for papers by José L. Pascual Breakdown of academic impact, for papers by Judith Charlton Breakdown of academic impact, for papers by David C. Rhew
Rankless by CCL
2026